Home Newsfeeds Redburn Partners Initiates Coverage On Boeing with Neutral Rating

Redburn Partners Initiates Coverage On Boeing with Neutral Rating

Redburn Partners analyst Olivier Brochet initiates coverage on Boeing (NYSE:BA) with a Neutral rating.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Redburn Partners analyst Olivier Brochet initiates coverage on Boeing (NYSE:BA) with a Neutral rating.

Analyst Ratings

Where Nevro Stands With Analysts

By Benzinga Insights

December 1, 3:00 PM

Within the last quarter, Nevro (NYSE:NVRO) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

NVRO

Airbnb Stock Tumbles Premarket Despite Q4 Beat: What’s Spooking Investors?

By Shanthi Rexaline

February 14, 8:50 AM

A cautious outlook, combined with the lack of specific details about the impact of Easter timing, seemed to be the catalysts.

ABNB

Analyst Ratings

HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here’s What You Need To Know

By Benzinga Insights

August 12, 12:19 PM

HC Wainwright & Co. has decided to maintain its Buy rating of RAPT Therapeutics (NASDAQ:RAPT) and raise its price target from $50.00 to $53.00. Shares of RAPT Therapeutics are trading up 14.98% over the last 24 hours, at $28.01 per share.

RAPT

News

Novo Integrated Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Benzinga Newsdesk

November 24, 10:22 AM

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo") today announced the Company has received notice from The Nasdaq Capital Market, LLC ("Nasdaq"), dated November 22, 2023, informing Novo that it has

NVOS

Redburn Partners Initiates Coverage On Boeing with Neutral Rating

Related Posts

Where Nevro Stands With Analysts

Airbnb Stock Tumbles Premarket Despite Q4 Beat: What’s Spooking Investors?

HC Wainwright & Co. Maintains Buy Rating for RAPT Therapeutics: Here’s What You Need To Know

Novo Integrated Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement